Works matching IS 09509232 AND DT 2010 AND VI 29 AND IP 37

Results: 11

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.

Published in:

Oncogene, 2010, v. 29, n. 37, p. 5135, doi. 10.1038/onc.2009.279

By:

Wheeler, S. E.;
Suzuki, S.;
Thomas, S. M.;
Sen, M.;
Leeman-Neill, R. J.;
Chiosea, S. I.;
Kuan, C-T.;
Bigner, D. D.;
Gooding, W. E.;
Lai, S. Y.;
Grandis, J. R.

Publication type:

Article

Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.

Published in:

Oncogene, 2010, v. 29, n. 37, p. 5171, doi. 10.1038/onc.2010.259

By:

Caron, C.;
Lestrat, C.;
Marsal, S.;
Escoffier, E.;
Curtet, S.;
Virolle, V.;
Barbry, P.;
Debernardi, A.;
Brambilla, C.;
Brambilla, E.;
Rousseaux, S.;
Khochbin, S.

Publication type:

Article

Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways.

Published in:

Oncogene, 2010, v. 29, n. 37, p. 5182, doi. 10.1038/onc.2010.251

By:

Lee, S-H.;
Bahn, J. H.;
Whitlock, N. C.;
Baek, S. J.

Publication type:

Article

Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis.

Published in:

Oncogene, 2010, v. 29, n. 37, p. 5159, doi. 10.1038/onc.2010.255

By:

Tessema, M.;
Klinge, D. M.;
Yingling, C. M.;
Do, K.;
Van Neste, L.;
Belinsky, S. A.

Publication type:

Article

Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells.

Published in:

Oncogene, 2010, v. 29, n. 37, p. 5214, doi. 10.1038/onc.2010.271

By:

Das, P. M.;
Thor, A. D.;
Edgerton, S. M.;
Barry, S. K.;
Chen, D. F.;
Jones, F. E.

Publication type:

Article

AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling.

Published in:

Oncogene, 2010, v. 29, n. 37, p. 5146, doi. 10.1038/onc.2010.258

By:

Kong, B.;
Michalski, C. W.;
Hong, X.;
Valkovskaya, N.;
Rieder, S.;
Abiatari, I.;
Streit, S.;
Erkan, M.;
Esposito, I.;
Friess, H.;
Kleeff, J.

Publication type:

Article

p53 isoforms gain functions.

Published in:

Oncogene, 2010, v. 29, n. 37, p. 5113, doi. 10.1038/onc.2010.266

By:

Olivares-Illana, V.;
Fåhraeus, R.

Publication type:

Article

Drug resistance in mutant FLT3-positive AML.

Published in:

Oncogene, 2010, v. 29, n. 37, p. 5120, doi. 10.1038/onc.2010.273

By:

Weisberg, E.;
Sattler, M.;
Ray, A.;
Griffin, J. D.

Publication type:

Article

H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3.

Published in:

Oncogene, 2010, v. 29, n. 37, p. 5193, doi. 10.1038/onc.2010.257

By:

Chakrabarty, A.;
Rexer, B. N.;
Wang, S. E.;
Cook, R. S.;
Engelman, J. A.;
Arteaga, C .L.

Publication type:

Article

Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis.

Published in:

Oncogene, 2010, v. 29, n. 37, p. 5204, doi. 10.1038/onc.2010.277

By:

Meng, L.;
Gabai, V. L.;
Sherman, M. Y.

Publication type:

Article

Why is p53-inducible gene 3 rarely affected in cancer?

Published in:

2010

By:

Kotsinas, A.;
Pateras, I. S.;
Galanos, P. S.;
Karamouzis, M. V.;
Sfikakis, P. P.;
Gorgoulis, V. G.

Publication type:

Letter